| THURSDAY, OCTOBER 1, 2020 | ||
| 08:45-09:00 | Dragana Sobic Saranovic, Vera Artiko, Aida Afgan, Belgrade | Welcome, Cardiovascular nuclear medicine in the era of multimodality imaging |
| 1.CARDIOMYOPATHIES-AMYLOIDOSIS: IMPORTANCE OF NUCLEAR MEDICINE | ||
| Chairpersons: Arsen Ristić | ||
| 09:00-09:15 | Arsen Ristić, Belgrade | Amyloidosis – cardiologist view |
| 09:15-09:30 | Sophia Koukouraki, Heraklion | Planar and hybrid SPECT/CT cardiac imaging in the assessment of cardiac transthyretin amyloidosis – Crete experience |
| 09:30-09:45 | Ružica Maksimović, Belgrade | MRI in cardiac amyloidosis |
| 09:45-10:00 | Venjamin Majstorov, Skopje | Cardiac imaging in the assessment of cardiac transthyretin amyloidosis – North Macedonia experience |
| 10:00-10:15 | Dragana Sobic Saranovic, Belgrade | Whole body DPD scintigraphy in cardiac transthyretin amyloidosis – experience of Center of Nuclear Medicine CCS |
| 10:15-10:25 | Discussion | |
| 2. ARTIFICIAL INTELLIGENCE IN CARDIOVASCULAR MEDICINE AND ACCESS TO HEALTHCARE | ||
| Chairpersons: Dragana Sobic Saranovic, Vera Artiko | ||
| 10:30-10:45 | Diana Paez, IAEA | Reducing Disparities in Access to Healthcare |
| 10:45-11:00 | Marcus Hacker, Vienna | Artificial Intelligence in nuclear medicine |
| 11:00-11:15 | Marko Grahovac, Vienna | AI algorithms in the multimodal imaging |
| 11:15-11:30 | Danijela Trifunovic Zamaklar, Belgrade | Artificial intelligence in echocardiogaphy |
| 11:30-11:40 | Discussion | |
| 3. REVASCULARIZATION: IMPORTANCE OF ISCHEMIA AND VIABILITY ASSESSMENT | ||
| Chairpersons: Nebojša Kozarević | ||
| 11:45-12:00 | Goran Stanković, Belgrade | Importance of ischemia and viability assessment for the decision of revascularization in heart failure |
| 12:00-12:15 | Nebojša Kozarević, Belgrade | SPECT in myocardial viability assessment |
| 12:15-12:30 | Vojislav Giga, Belgrade | Noninvasive assessment of CAD: is there a method of chioice? |
| 12:30-12:45 | Radosav Vidaković, Belgrade | Assessment of anatomy and function in coronary artery disease – role of CT and MRI |
| 12:45-12:55 | Discussion | |
| 4. QUANTIFICATION OF CORONARY FLOW AND ISCHEMIA: IS IT IMPORTANT? | ||
| Chairpersons: Dragana Sobic Saranovic | ||
| 13:00-13:15 | Raffaele Giubbini, Brescia | Measuring myocardial blood flow in the era of multimodality imaging |
| 13:15-13:30 | Branko Beleslin, Belgrade | Complex relation between invasive flow evaluation and ischemia! How to define myocardial ischemia in 2020? |
| 13:30-13:45 | Ana Djordjević Dikić, Belgrade | Diagnosis and risk stratification of coronary microvascular disease: Role of stress testing and noninvasive imaging |
| 13:45-14:00 | Sabina Dizdarević, Brighton | Role of gated Myocardial perfusion in pre operative risk assessment prior to AAA repair |
| 14:00-14:15 | Discussion | |
| FRIDAY, OCTOBER 2, 2020 | ||
| 5. CARDIOVASCULAR INFECTION AND INFLAMMATION | ||
| Chairpersons: Vera Artiko, Isidora Grozdic Milojevic | ||
| 09:00-09:15 | Sobhan Vinjamuri, Liverpool | Incidental cardiac uptake on Ga68 DOTA scans. What does it mean? |
| 09:15-09:30 | Jovica Šaponjski, Belgrade | Role of MSCT in vasculitis |
| 09:30-09:45 | Isidora Grozdic Milojevic, Belgrade | The role of FDG PET/CT in cardiac sarcoidosis |
| 09:45-10:00 | Raluca Mititelu, Bucharest | The role of PET/CT in endocarditis |
| 10:00-10:15 | Vasilios Prasopoulos, Athens | The role of FDG PET/CT in the investigation of clinical suspicious of vasculitis |
| 10:15-10:25 | Discussion | |
| 6. CARDIO-ONCOLOGY AND CARDIO-NEUROLOGY: IMPORTANCE IN CLINICAL PRACTICE | ||
| Chairpersons: Branislava Ivanović, Snežana Šušnjar | ||
| 10:30-10:45 | Branislava Ivanović, Belgrade | Cardio-oncology:The mirror has two faces |
| 10:45-11:00 | Snežana Šušnjar, Belgrade | Why oncologists need cardiologists? |
| 11:00-11:15 | Jelena Petrović, Dragana Šobić Šaranović, Belgrade | MUGA scan in cardiac toxicity |
| 11:15-11:30 | Maria Koutelu, Athens | Cardiac neurotransmission imaging in heart diseases |
| 11:30-10:45 | Milica Stojijkovic,Leposava Brajković, Dragana Šobić Šaranović, Belgrade | Cardiac neurotransmission imaging in neurological disorders: eight years of experience of Center for Nuclear Medicine, CCS |
| 11:45-11:55 | Discussion | |
| 7. CHRONIC CORONARY SYNDROME AND NUCLEAR MEDICINE | ||
| Chairpersons: Dragana Sobic Saranovic | ||
| 12:00-12:15 | Siniša Stanković, Banja Luka | SPECT MPI in Diabetes type 2 patients: expirience in Banja Luka |
| 12:15-12:30 | Jasna Mihailovic, Novi Sad | Myocardial pefusion imaging in low risk patients for coronary artery disease with symptoms |
| 12:30-12:45 | Amela Begić, Sarajevo | Myocardial perfusion imaging in detection of ischemia: expirience in Sarajevo |
| 12:45-13:00 | Branislav Baškot, Belgrade | SPECT MPI in chronic coronary syndrome: expiriencein private practice |
| 13:00-13:15 | Miloš Stević, Niš | Myocardial perfusion imaging in detection of ischemia: expirience in Niš |
| 13:15-13:30 | Katarina Nikoletic, Drummen | Nuclear cardiology in Norway |
| 13:30-13:45 | Discussion | |
| 13:45-14:00 | Closing Remark | |